R Klapdor
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
-
- Genetic factors in colorectal cancer
Papers in
- Co-authors
- C. Sturgeon (2 shared papers)A. van Dalen (2 shared papers)Caj Haglund (2 shared papers)R. Lamerz (2 shared papers)Ondřej Topolčan (2 shared papers)Lars‐Erik Hansson (2 shared papers)Michael J. Duffy (2 shared papers)Païvi Peltomäki (1 shared paper)
- Journals
- European Journal of Cancer (4 papers)Nuklearmedizin - NuclearMedicine (4 papers)Journal of Molecular Medicine (2 papers)Langenbeck s Archives of Surgery (2 papers)Gastroenterology (2 papers)
- Partner nations
- GermanyFinlandUnited Kingdom
In The Last Decade
R Klapdor
73 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Oncology 774
- Pathology and Forensic Medicine 272
- Cancer Research 225
- Reproductive Medicine 73
- Hepatology 63
Countries citing papers authored by R Klapdor
This map shows the geographic impact of R Klapdor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Klapdor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Klapdor more than expected).
Fields of papers citing papers by R Klapdor
This network shows the impact of papers produced by R Klapdor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Klapdor. The network helps show where R Klapdor may publish in the future.
Co-authors
The 25 scholars most cited alongside R Klapdor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 393 | |
| 2 | 2003 | 300 | |
| 3 | 1999 | 98 | |
| 4 | 1986 | 85 | |
| 5 | 1991 | 69 | |
| 6 | Parenteral nutrition support for patients with pancreatic cancer--improvement of the nutritional status and the therapeutic outcome. | 2012 | 49 |
| 7 | 1986 | 34 | |
| 8 | 1988 | 22 | |
| 9 | Fluctuations of tumor markers in heart failure patients pre and post heart transplantation. | 1999 | 22 |
| 10 | Irinotecan(Campto R): efficacy as third/forth line therapy in advanced pancreatic cancer. | 2001 | 21 |
| 11 | Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers. | 1999 | 19 |
| 12 | 1992 | 18 | |
| 13 | CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. | 1999 | 16 |
| 14 | Immunoscintigraphy and radioimmunotherapy in patients with pancreatic carcinoma. | 1986 | 16 |
| 15 | Improved sensitivity of fuzzy logic based tumor marker profiles for diagnosis of pancreatic carcinoma versus benign pancreatic disease. | 2001 | 15 |
| 16 | 1988 | 13 | |
| 17 | 1977 | 13 | |
| 18 | Perspectives in chemotherapy of pancreatic cancer. | 1991 | 12 |
| 19 | Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases. | 1985 | 11 |
| 20 | 1999 | 10 |
About R Klapdor
R Klapdor is a scholar working on Oncology, Surgery, Epidemiology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Neuroendocrine Tumor Research Advances (12 papers), Cancer Research and Treatments (9 papers), Cancer Genomics and Diagnostics (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Pancreatitis Pathology and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Oncology (774 citations), Pathology and Forensic Medicine (272 citations), Cancer Research (225 citations), Reproductive Medicine (73 citations) and Hepatology (63 citations). R Klapdor has collaborated with scholars based in Germany, Finland and United Kingdom. Frequent co-authors include C. Sturgeon, A. van Dalen, Caj Haglund, R. Lamerz, Ondřej Topolčan, Lars‐Erik Hansson, Michael J. Duffy, Païvi Peltomäki, Elke Holinski‐Feder and Ola Nilsson. Their work appears in journals such as European Journal of Cancer, Nuklearmedizin - NuclearMedicine, Journal of Molecular Medicine, Langenbeck s Archives of Surgery and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.